Deep brain stimulation and cognitive decline in Parkinson's disease: a clinical review.

Frontiers in Neurology
João Massano, Carolina Garrett

Abstract

Parkinson's disease is a common and often debilitating disorder, with a growing prevalence accompanying global population aging. Current drug therapy is not satisfactory enough for many patients, especially after a few years of symptom progression. This is mainly due to the motor complications that frequently emerge as disease progresses. Deep brain stimulation (DBS) is a useful therapeutic option in carefully selected patients that significantly improves motor symptoms, functional status, and quality of life. However, cognitive impairment may limit patient selection for DBS, as patients need to have sufficient mental capabilities in order to understand the procedure, as well as its benefits and limitations, and cooperate with the medical team throughout the process of selection, surgery, and postsurgical follow-up. On the other hand it has been observed that certain aspects of cognitive performance may decline after DBS, namely when the therapeutic target is the widely used subthalamic nucleus. These are important pieces of information for patients, their families, and health care professionals. This manuscript reviews these aspects and their clinical implications.

Citations

Jul 21, 2012·Der Nervenarzt·F Steigerwald, J Volkmann
May 18, 2013·Journal of Neurology·Han-Joon KimSun Ha Paek
Oct 11, 2012·Neurology Research International·Edward A Shipton
Jun 22, 2014·IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society·Samantha R SummersonCaleb T Kemere
Oct 28, 2017·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Alexander I Tröster
Jun 9, 2018·The International Journal of Neuroscience·Asmat Ullah KhanRida Zainab
Oct 11, 2017·International Psychogeriatrics·Hamilton MorrinAnto P Rajkumar
Sep 28, 2016·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Alfonso FasanoRenato Puppi Munhoz
Oct 27, 2018·Movement Disorders Clinical Practice·Laura J WeinkleOlga Klepitskaya
May 30, 2014·Neurologia Medico-chirurgica·Takashi AsahiSatoshi Kuroda
Apr 12, 2016·Journal of Parkinson's Disease·Jean-Paul BouwynDavid Maltête
Dec 18, 2019·Dementia & Neuropsychologia·Eduarda Naidel Barboza E Barbosa, Helenice Charchat Fichman
Jan 3, 2021·Journal of Parkinson's Disease·Katarzyna SmilowskaK Ray Chaudhuri
Jun 23, 2021·Journal of Speech, Language, and Hearing Research : JSLHR·Sandra H VosVitória Piai

❮ Previous
Next ❯

Software Mentioned

COMPARE

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Christine DanielsKarsten Witt
British Medical Bulletin
C A Davie
Movement Disorders : Official Journal of the Movement Disorder Society
Robert G HartJohn R Marler
Lancet Neurology
A Jon StoesslVesna Sossi
© 2021 Meta ULC. All rights reserved